ITGA1促进质瘤细胞的扩散,并影响低级质瘤中免疫细胞的透
Yanhong Ren1, Jianchang Xu2, Zhengkui Zhang1
1Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, West Huai-Hai Road 99, Xuzhou, Jiangsu, China.
Mediators of inflammation
|November 6, 2024
概括
在低度质瘤 (LGG) 中,因特林α1 (ITGA1) 的高表达与免疫细胞透率的增加相关,并预测这种中枢神经系统癌症患者的预后不佳.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 低度质瘤 (LGG) 是一种普遍存在的中枢神经系统癌症.
- 整蛋白α1 (ITGA1) 涉及癌症进展,但其在质瘤中的作用尚不清楚.
- 这项研究调查了ITGA1在LGG中的预后意义.
研究的目的:
- 评估Integrin α1 (ITGA1) 在低度质瘤 (LGG) 的预后价值.
- 探索ITGA1表达,免疫透和LGG的临床结果之间的相关性.
主要方法:
- 在LG数据集 (CGGA,TCGA) 和临床样本中分析ITGA1表达.
- 使用考克斯回归和生存分析评估ITGA1的预后价值.
- 通过GSEA调查ITGA1介导的生物功能,以及与免疫细胞透和检查点基因的相关性.
主要成果:
- 与正常组织相比,LGG的ITGA1表达显著增加.
- 高ITGA1表达是LGG患者预后不佳的独立风险因素.
- ITGA1与免疫评分,肌评分和免疫检查点基因表达相关,并促进质瘤细胞入侵.
结论:
- 在LGG中提升ITGA1表达与增加的免疫透有关.
- 高ITGA1表达是LGG患者预后不良的预测生物标志物.
- 针对ITGA1可能为LGG提供治疗策略.
相关概念视频
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


